アタキシン-1誘発性神経変異を修正する遺伝子の特定
P Fernandez-Funez1, M L Nino-Rosales, B de Gouyon
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Nature
|November 18, 2000
まとめ
ドロソフィラのSCA1 (Spinocerebellar ataxia type 1) 研究は,野生型アタキシン-1の高濃度が神経変性を引き起こすことを明らかにしています. 遺伝子スクリーンは,タンパク質の折りたたみ,クリアランス,RNA処理,解毒における重要な経路を特定しました.
科学分野:
- 神経科学は神経科学である.
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- Spinocerebellar ataxia type 1 (SCA1) を含む神経変性疾患は,疾患に関連するタンパク質のポリグルタミン経路の拡張によってしばしば引き起こされます.
- タンパク質アタクシン-1は,拡張されたポリグルタミン経路を含んでいる場合,SCA1の病原性に関与しています.
研究 の 目的:
- SCA1とその基礎となる分子機構を研究するためのドロソフィラモデルを確立する.
- SCA1誘発の神経変異の遺伝子変形因子を特定し,疾患経路を明らかにする.
主な方法:
- ドロソフィラの全長ヒトSCA1遺伝子の発現により,疾患モデルを作成する.
- SCA1誘発の神経変異を修正する遺伝子を特定するために,ドロソフィラの遺伝子スクリーニングを実施.
主要な成果:
- ドロソフィラの野生型アタキシン-1の高いレベルは,拡張型アタキシン-1によって引き起こされるものと同様の変性現象を誘発した.
- タンパク質の折りたたみ,タンパク質クリアランス,RNA処理,転写調節,細胞解毒に関与する遺伝子改変剤を特定した.
結論:
- ドロソフィラモデルは,SCA1神経変異の重要な側面を効果的に再現しています.
- 発見は,ポリグルタミン疾患の病原性におけるタンパク質品質管理,RNA代謝,細胞解毒の重要性を強調しています.
- これらの洞察は,SCA1およびアルツハイマー病やパーキンソン病などの他の神経変性疾患の治療戦略を参考にすることができます.
関連する概念動画
02:08Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
02:23RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:30Point and Frameshift Mutations
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...